101 related articles for article (PubMed ID: 2093210)
1. Production of interleukin-6 from macrophages by MDP-Lys (L 18), romurtide.
Shimoda K; Okamura S; Harada N; Omori F; Niho Y
Res Commun Chem Pathol Pharmacol; 1990 Dec; 70(3):289-96. PubMed ID: 2093210
[TBL] [Abstract][Full Text] [Related]
2. Production of colony-stimulating factor from macrophages by muroctasin.
Yamaguchi F; Akahane K; Takashi T; Tsukada W
Arzneimittelforschung; 1988 Jul; 38(7A):983-6. PubMed ID: 3263870
[TBL] [Abstract][Full Text] [Related]
3. Stimulatory effect of romurtide on hematopoiesis in monkeys.
Nakajima R; Yshida Y; Akahane K; Sekiguchi M; Osada Y
Arzneimittelforschung; 1991 Jan; 41(1):60-5. PubMed ID: 2049113
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo effects of MDP-Lys(L18) on mouse megakaryocyte progenitor cells (CFU-Meg).
Komiya I; Kuriya S; Akahane K; Nomura T
Exp Hematol; 1992 May; 20(4):517-22. PubMed ID: 1568468
[TBL] [Abstract][Full Text] [Related]
5. Stimulation of macrophages by muroctasin to produce colony-stimulating factors.
Akahane K; Yamaguchi F; Kita Y; Une T; Osada Y
Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):179-83. PubMed ID: 1692219
[TBL] [Abstract][Full Text] [Related]
6. Synergistic generation of tumoricidal macrophages by muroctasin and interferon-gamma.
Nagao S; Sato K; Osada Y
Arzneimittelforschung; 1988 Jul; 38(7A):999-1002. PubMed ID: 3142490
[TBL] [Abstract][Full Text] [Related]
7. Specific binding sites of muroctasin on murine macrophages.
Akasaki M; Masayasu H; Tsukada W; Takegoshi T
Arzneimittelforschung; 1988 Jul; 38(7A):978-80. PubMed ID: 3190804
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo augmentation by muroctasin of the production of the third component of complement by murine macrophages.
Endo N
Arzneimittelforschung; 1988 Jul; 38(7A):993-6. PubMed ID: 3190805
[TBL] [Abstract][Full Text] [Related]
9. Elevation by muroctasin of the serum level of the complement subcomponent C1q in mice and of its biosynthesis by cultured mouse peritoneal macrophages.
Endo N; Okuda T; Osada Y; Zen-yoji H
Arzneimittelforschung; 1990 Jan; 40(1):58-61. PubMed ID: 2340001
[TBL] [Abstract][Full Text] [Related]
10. Muroctasin [MDP-Lys(18)] augments the production of granulocyte colony-stimulating factor (G-CSF) from human peripheral blood mononuclear cells in vitro.
Shimoda K; Okamura S; Kawasaki C; Omori F; Matsuguchi T; Niho Y
Int J Immunopharmacol; 1990; 12(7):729-36. PubMed ID: 1705535
[TBL] [Abstract][Full Text] [Related]
11. Augmentation by priming with interferon-gamma of the binding of a muramyl dipeptide derivative to macrophages resulting in synergistic macrophage activation.
Nagao S; Sato K; Osada Y
Jpn J Cancer Res; 1987 Jan; 78(1):80-6. PubMed ID: 3102442
[TBL] [Abstract][Full Text] [Related]
12. Activation of immune responses by muroctasin.
Akasaki M
Arzneimittelforschung; 1988 Jul; 38(7A):976-7. PubMed ID: 3056427
[TBL] [Abstract][Full Text] [Related]
13. Induction of colony-stimulating factor and stimulation of stem cell proliferation by injection of muroctasin.
Yamaguchi F; Akasaki M; Tsukada W
Arzneimittelforschung; 1988 Jul; 38(7A):980-3. PubMed ID: 3263869
[TBL] [Abstract][Full Text] [Related]
14. Acute and chronic polyarthritis induced by an aqueous form of 6-O-acyl and N-acyl derivatives of N-acetylmuramyl-L-alanyl-D-isoglutamine in euthymic rats and athymic nude rats.
Kohashi O; Kohashi Y; Shigematsu N; Ozawa A; Kotani S
Lab Invest; 1986 Sep; 55(3):337-46. PubMed ID: 3489128
[TBL] [Abstract][Full Text] [Related]
15. Stimulation of plasma fibronectin production in mice by muroctasin.
Endo N; Okuda T; Osada Y; Zen-Yoji H
Arzneimittelforschung; 1988 Jul; 38(7A):997-8. PubMed ID: 3190806
[TBL] [Abstract][Full Text] [Related]
16. Muramyl dipeptide-Lys stimulates the function of human dendritic cells.
Todate A; Suda T; Kuwata H; Chida K; Nakamura H
J Leukoc Biol; 2001 Nov; 70(5):723-9. PubMed ID: 11698491
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory cytokine production induced by an analogue of muramyl dipeptide MDP-Lys(L18) in rat macrophage cultures and dog synovial fluid.
Sugawara T; Takada S; Miyamoto M; Nomura M; Kato M
Inflammation; 1996 Feb; 20(1):43-56. PubMed ID: 8926048
[TBL] [Abstract][Full Text] [Related]
18. Differences in interleukin 1 (IL-1), IL-6, tumor necrosis factor and IL-1 receptor antagonist production by human monocytes stimulated with muramyl dipeptide (MDP) and its stearoyl derivative, romurtide.
Suzuki K; Torii K; Hida S; Hayashi H; Hiyama Y; Oomoto Y; Takii T; Chiba T; Onozaki K
Immunopharmacology; 1994; 28(1):31-8. PubMed ID: 7928300
[TBL] [Abstract][Full Text] [Related]
19. Mutagenicity studies of muroctasin.
Shimada H; Hattori C; Sato T
Arzneimittelforschung; 1988 Jul; 38(7A):1031-3. PubMed ID: 3056424
[TBL] [Abstract][Full Text] [Related]
20. Stimulation of non-specific resistance to infection by muroctasin.
Otani T; Une T; Osada Y
Arzneimittelforschung; 1988 Jul; 38(7A):969-76. PubMed ID: 3056426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
